Cardiorespiratory Fitness, Non Small Cell Lung Cancer, Prehabilitation, Surgery
Conditions
Keywords
Prehabilitation, Cardiorespiratory fitness, Non-small cell lung cancer, Exercise, Wearable technology, Surgery
Brief summary
To explore the safety and compliance of a wearable telemedicine device that can receive basic vital signs in real time, and its active supervision mode with real-time adjustment of exercise prescription for preoperative prehabilitation exercises in patients at home; and to evaluate the effectiveness of preoperative prehabilitation exercises in a telemedicine active supervision mode in patients undergoing thoracoscopic lung tumour resection, taking into account the patient's cardiopulmonary exercise test, postoperative complications and quality of life scores.
Interventions
4 weeks of an supervised, pre-operative exercise prescription augmented by a wearable fitness device.
Sponsors
Study design
Eligibility
Inclusion criteria
1. Capacity to give informed consent. 2. Are able to tolerate surgery (i.e., segmentectomy, lobectomy) as indicated by standard clinical pre-op evaluation, including pulmonary function tests and cardiopulmonary exercise testing. 3. Patients who can use a smartphone application. 4. Patients who are diagnosed of stage I or II Non-small-cell lung carcinoma (NSCLC) diagnosis, with or without pre-operative histologic confirmation. 5. Patients who can perform an exercise program for at least 4 weeks from the first visit to the preoperative clinic to elective surgery.
Exclusion criteria
1. Known contraindication for cardiopulmonary exercise testing. 2. Patients who have a major medical or psychiatric disorder that is expected to affect exercise. 3. Pregnancy or lactating women.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Study feasibility | Baseline, 4 weeks after prehabilitation exercise | Assessed by the following indicators: study participation rate, screening and enrollment rates, intervention completion rate, number of completed exercise days, wearable-device wearing days and wearing rate, analyzable activity days, paper-log completion, app-based electronic-log completion, alert generation and closure, intervention discontinuation, adverse events, and serious adverse events |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Pre-post changes in cardiopulmonary exercise testing | Baseline, 4 weeks of prehabilitation exercise | Peak oxygen uptake, peak workload, anaerobic-threshold measures |
| Forced expiratory volume in 1 s(FEV1) | Baseline, 4 weeks after prehabilitation exercise, 7 days after surgery, 30 days after surgery | Forced expiratory volume in 1 s (FEV1) of pulmonary function will be measured in liters |
| Forced vital capacity (FVC) | Baseline, 4 weeks after prehabilitation exercise, 7 days after surgery, 30 days after surgery | Forced vital capacity (FVC) of pulmonary function will be measured in liters. |
| Change in quality of life | Baseline, 4 weeks after prehabilitation exercise, 7 days after surgery, 30 days after surgery | as assessed by the EORTC QLQ C30 questionnaire |
| Post-operative complications | 30-days after surgery (T4) | Classified using the Clavien Dindo Classification |
| Moderate to vigorous physical activity | Baseline, 4 weeks of prehabilitation exercise | Daily total minutes of moderate to vigorous physical activity (MVPA) |
Countries
China